Decreasing prematurity in twin gestations: predicaments and possibilities
Noelia Zork1, Joseph Biggio, Alan Tita
1Department of Obstetrics and Gynecology, division of Maternal-Fetal Medicine, Columbia University, New York, New York; the University of Alabama at Birmingham, Birmingham, Alabama; and Brown University, Providence, Rhode Island.
Obstetrics and Gynecology
|August 24, 2013
Summary
Twin birth rates are rising due to reproductive technologies. Current preterm birth prevention methods are ineffective for twins, but vaginal progesterone and cervical pessaries show promise for those with short cervices.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Reproductive Endocrinology
Background:
- The twin birth rate has significantly increased, largely due to assisted reproductive technologies.
- Despite progress in singleton preterm birth prevention, the overall preterm birth rate has seen minimal decline.
- Existing interventions for preventing preterm birth in twins have largely been ineffective.
Discussion:
- Inpatient bed rest is not effective and poses risks for maternal morbidity.
- Intramuscular 17α-hydroxyprogesterone caproate and cerclage are ineffective for preventing preterm birth in twin gestations, even with a short cervix.
- Emerging evidence suggests vaginal progesterone and the Arabin cervical pessary may reduce preterm birth in twins with a short cervix.
Key Insights:
- No current interventions are reliably effective in preventing preterm birth in twin pregnancies.
- Vaginal progesterone and cervical pessaries show potential benefit for a specific subgroup of twin pregnancies (those with a short cervix).
- Further research is critical to validate these promising findings.
Outlook:
- Large-scale, multicenter trials are necessary to definitively assess the efficacy of vaginal progesterone and cervical pessaries in twin gestations.
- Investigating novel therapeutic strategies for preterm birth prevention in twins remains a critical area of research.
- Improving outcomes for twin pregnancies requires targeted interventions and robust clinical evidence.
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

